Extendicare Inc. (TSE:EXE – Get Free Report) shares hit a new 52-week high during trading on Monday . The stock traded as high as C$13.13 and last traded at C$13.08, with a volume of 67465 shares changing hands. The stock had previously closed at C$13.04.
Analyst Ratings Changes
Several research analysts have recently weighed in on the company. Cormark raised Extendicare to a “moderate buy” rating in a research note on Wednesday, February 19th. BMO Capital Markets upped their price objective on shares of Extendicare from C$11.00 to C$13.50 in a research report on Monday, March 3rd. Royal Bank of Canada boosted their target price on shares of Extendicare from C$9.50 to C$11.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 28th. Finally, TD Securities raised their price target on shares of Extendicare from C$10.50 to C$13.00 and gave the company a “hold” rating in a research note on Monday, March 3rd. Three investment analysts have rated the stock with a hold rating and one has assigned a buy rating to the company. Based on data from MarketBeat, Extendicare has an average rating of “Hold” and a consensus target price of C$11.50.
Check Out Our Latest Stock Analysis on EXE
Extendicare Trading Up 0.2 %
Extendicare Dividend Announcement
The company also recently disclosed a monthly dividend, which will be paid on Monday, March 17th. Investors of record on Monday, March 17th will be issued a $0.04 dividend. The ex-dividend date is Friday, February 28th. This represents a $0.48 annualized dividend and a dividend yield of 3.68%. Extendicare’s dividend payout ratio is presently 61.20%.
Extendicare Company Profile
Extendicare Inc, operating solely in Canada, is the largest private-sector owner and operator of long-term care (LTC”) homes and one of the largest private-sector providers of publicly funded home health care services.
Featured Articles
- Five stocks we like better than Extendicare
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- S&P 500 & Nasdaq Hit Critical Support—Will Stocks Hold or Fall?
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- Silver Pushes Past Gold This Year, These Stocks Will Capitalize
- How to Invest in Insurance Companies: A Guide
- These 3 Q1 Earnings Winners Will Go Higher
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.